MedTrace Logo

Effects of a Web-Based Alopecia Education Program in Women With Breast Cancer

NCT07724314 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2026-07-24

No results posted yet for this study

Summary

This randomized controlled trial evaluated the effects of a web-based alopecia education program on body image, self-esteem, chemotherapy-induced alopecia-related quality of life, and psychological well-being among women with breast cancer receiving chemotherapy. A total of 68 women were randomly assigned to the intervention or routine-care control group. Participants in the intervention group received access to a web-based educational and supportive care program throughout chemotherapy, whereas participants in the control group received routine care. Outcomes were assessed at predefined time points before the first, second, and final chemotherapy cycles.

Conditions

Interventions

BEHAVIORAL

Web-Based Alopecia Education Program

A structured web-based educational and supportive care program designed for women with breast cancer receiving chemotherapy. The program included information about chemotherapy-induced alopecia, the expected course of hair loss and regrowth, preparation before hair loss, hair and scalp care, use of wigs and head coverings, appearance-related concerns, and strategies for coping with emotional and social effects.

Sponsors & Collaborators

  • Gulay Akman

    lead OTHER

Principal Investigators

  • Gulay Akman, PhD · Faculty of Health Sciences, Ondokuz Mayıs University, Samsun, Turkey

  • Hatice Balci Yangin, PhD · Faculty of Nursing, Akdeniz University, Antalya, Turkey

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-02
Primary Completion
2019-05-03
Completion
2019-05-03

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07724314 on ClinicalTrials.gov